Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Jennifer E. Cook

Director at BridgeBio Pharma, Inc. (BBIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $21.9M

Reported trades

Filed Stock Type Shares Price Value Since
Jul 13SEC BBIOBridgeBio Pharma, Inc. Sell Plan 36,167120,805 held (−23%) $84.00 $3.0M -22.2%
Jul 13SEC BBIOBridgeBio Pharma, Inc. Sell Plan 112,4228,383 held (−93%) $90.00 $10.1M -27.4%
Jun 24SEC BBIOBridgeBio Pharma, Inc. Sell Plan 2,1968,383 held (−21%) $68.57 $151K -4.7%
Jun 24SEC BBIOBridgeBio Pharma, Inc. Sell Plan 37,1678,383 held (−82%) $70.00 $2.6M -6.6%
Jun 17SEC BBIOBridgeBio Pharma, Inc. Sell Plan 88,7378,092 held (−92%) $66.62 $5.9M -1.9%
Jun 17SEC BBIOBridgeBio Pharma, Inc. Sell Plan 1,5036,589 held (−19%) $67.14 $101K -2.7%
  • Sell

    Director Jennifer E. Cook sold $3.0M of BBIO at $84.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jennifer E. Cook sold $10.1M of BBIO at $90.00 — cuts the stake by 93%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jennifer E. Cook sold $151K of BBIO at $68.57 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jennifer E. Cook sold $2.6M of BBIO at $70.00 — cuts the stake by 82%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jennifer E. Cook sold $5.9M of BBIO at $66.62 — cuts the stake by 92%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jennifer E. Cook sold $101K of BBIO at $67.14 — pre-scheduled 10b5-1 plan sale.